American adults are wary of pharmaceutical company messaging

News
Article

KFF poll finds credibility gap between drug-makers and consumers.

Credibility and cost may be two reasons why your patients aren’t taking their prescription medications.

KFF Health Tracking Poll 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs,” focused partly on the emerging trend of pharmaceuticals used to treat type 2 diabetes and expanding to the weight loss industry treating people for overweight and obesity.

KFF also asked respondents about larger issues affecting the contemporary American pharmaceutical market. Among the findings: Americans don’t entirely trust medicine-makers and a growing number of patients think there’s not enough regulation on prescription drug prices.

Here’s what else KFF found.

Related Videos
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Robert E. Oshel, PhD
Related Content
© 2023 MJH Life Sciences

All rights reserved.